Regulus Therapeutics 10K Form

Sell

30

RGLS
Regulus Therapeutics

Last Price:

$1.54

Seasonality Move:

7.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-09	10Q	RGLS/Regulus Therapeutics Quarterly
2023-11-09	10Q	RGLS/Regulus Therapeutics Quarterly
2023-08-08	10Q	RGLS/Regulus Therapeutics Quarterly
2023-05-11	10Q	RGLS/Regulus Therapeutics Quarterly
2022-11-14	10Q	RGLS/Regulus Therapeutics Quarterly
2022-08-11	10Q	RGLS/Regulus Therapeutics Quarterly

Receive RGLS News And Ratings

See the #1 stock for the next 7 days that we like better than RGLS

RGLS Financial Statistics

Sales & Book Value

Annual Sales:	$10M
Cash Flow:	$-9.5M
Price / Cash Flow:	0
Annual Sales:	$1.33
Price / Book:	1.16

Profitability

EPS (TTM):	-1.06000
Net Income (TTM):	$-41.6M
Gross Margin:	$0
Return on Equity:	0%
Return on Assets:	0%

Regulus Therapeutics Earnings Forecast

Key Regulus Therapeutics Financial Ratios

The Gross Profit Margin over the past 7 years for RGLS is 0.00%.
The Selling, General & Administrative Expenses for RGLS have been equal to 88.09% of Gross Profit Margin.
The Interest Expense is -2.01% of Operating Income.
Per Share Earnings over the last 14 years have been positive in 11 years.

Regulus Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	RGLS
CUSIP:	75915K
Website:	regulusrx.com

Debt

Debt-to-Equity Ratio:	0
Current Ratio:	0
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

RGLS Technical Analysis vs Fundamental Analysis

Sell

30

Regulus Therapeutics (RGLS) is a Sell

Is Regulus Therapeutics a Buy or a Sell?

Regulus Therapeutics stock is rated a Sell

The current Regulus Therapeutics [RGLS] share price is $1.54. The Score for RGLS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.